Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 37 of 295 for:    IFNA2 AND PEG-interferon alfa-2b

PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00276523
Recruitment Status : Completed
First Posted : January 13, 2006
Last Update Posted : October 31, 2012
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2006
Actual Study Completion Date : March 2006